Boston Scientific Beats Q3 EPS, Guides Q4 Below Consensus
Boston Scientific reported Q3 adjusted EPS of $0.73, $0.01 above consensus. It guided Q4 EPS and revenue below consensus.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.